Abstract |
Promotion of apoptosis in cancer cells could potentially lead to the regression and improved prognosis of hormone-refractory prostate cancer. Xanthohumol (XN), a prenylated chalcone-derived from hops, has shown strong antitumorigenic activity towards diverse types of cancer cells. In the present study, the growth-inhibitory and apoptosis-inducing activity of XN was tested in hormone-sensitive and hormone-refractory human prostate cancer cells lines. Cell growth/viability assay (MTS) demonstrated that prostate cancer cells are highly sensitive to XN at a concentration range of 20-40 μM. The primary mode of tumor cell destruction was apoptosis as demonstrated by the binding of annexin V-FITC, cleavage of PARP-1, activation of procaspases -3, -8, and -9, mitochondrial depolarization and release of cytochrome c from mitochondria. Induction of apoptosis by XN was associated with the inhibition of prosurvival Akt, NF-κB and mTOR signaling proteins and NF-κB-regulated anti-apoptotic Bcl-2 and survivin. These studies provide a rationale for clinical evaluation of XN for the treatment of hormone-refractory metastatic prostate cancer.
|
Authors | D Deeb, X Gao, H Jiang, A S Arbab, S A Dulchavsky, S C Gautam |
Journal | Anticancer research
(Anticancer Res)
Vol. 30
Issue 9
Pg. 3333-9
(Sep 2010)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 20944105
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Antineoplastic Agents
- Flavonoids
- Plant Extracts
- Propiophenones
- xanthohumol
|
Topics |
- Antineoplastic Agents
(pharmacology)
- Apoptosis
(drug effects)
- Blotting, Western
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Flavonoids
(pharmacology)
- Humans
- Humulus
(chemistry)
- Male
- Membrane Potential, Mitochondrial
(drug effects)
- Phytotherapy
(methods)
- Plant Extracts
(pharmacology)
- Propiophenones
(pharmacology)
- Prostatic Neoplasms
(metabolism)
- Signal Transduction
(drug effects)
|